Another biotech CEO to leave Rudnic departs as head of MiddleBrook as part of a $100M cash infusion \ Featured Jobs For the second time in two weeks, a giant of Marylands biotech industry has announced plans to step down.More News Last week it was CEO David M.
Mott...
MiddleBrook Pharmaceuticals secures $100M investment MiddleBrook Pharmaceuticals Inc.has announced a $100 million private equity investment to help bring its lead drug to market a milestone for the company, but disappointing for investors who expected a buyout.
Thwarting immediate plans...
MiddleBrook Pharmaceuticals Gets $100M Equity Deal, Make Management Changes (FinancialWire) MiddleBrook Pharmaceuticals (NASDAQ: MBRK) has made a deal for a $100 million equity infusion from Equity Group Investments LLC after more than a year of searching for a potential buyer or partner.As part of the $100...
MiddleBrook Pharmaceuticals Gets $100M Equity Deal, Make Management Changes (FinancialWire) MiddleBrook Pharmaceuticals (NASDAQ: MBRK) has made a deal for a $100 million equity infusion from Equity Group Investments LLC after more than a year of searching for a potential buyer or partner.As part of the $100...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) Strategic Review Results in $100MM Investment by Equity Group Investments;Experienced Commercial Executive Management Team Appointed;Preparing for Potential MOXATAG Launch in the First Half of 2009 GERMANTOWN, Md., July 1 /PRNewswire...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
Shares of MiddleBrook Pharmaceuticals Tumble On Resignation Of President, CEO (RTTNews) - Shares of pharmaceutical company MiddleBrook Pharmaceuticals, Inc.(MBRK | Quote | Chart | News | PowerRating) plunged Wednesday morning after the company announced the resignation of the company's President and CEO Edward...
MiddleBrook Pharmaceuticals shares plunge on $100 million equity deal, management change - 1:35 p.m.NEW YORK (AP) - Shares of MiddleBrook Pharmaceuticals plunged Wednesday as the company made a deal for a $100 million equity infusion after more than a year searching for a potential buyer or partner.
The stock dove $1.61, or...
Middlebrook Pharma gets $100M investment GERMANTOWN, Md.- Drug maker MiddleBrook Pharmaceuticals Inc.
said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell $1.56,...
Middlebrook Pharma gets $100M investment Drug maker MiddleBrook Pharmaceuticals Inc.said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell $1.56, or 51 percent, to ...
Middlebrook Pharma CEO, CFO to leave under $100 million investment deal, shares plunge GERMANTOWN, Md.(AP) - Drug maker MiddleBrook Pharmaceuticals Inc.
said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell ...
Middlebrook Pharma gets $100M investment Shares fell $1.56, or 51 percent, to $1.51 in premarket trading, having closed Tuesday's regular session at $3.07.Middlebrook is selling 30.3 million common shares at $3.30 each to Equity Group and a five-year warrant to buy 12.1 million...
Middlebrook Pharma gets $100M investment GERMANTOWN, Md.(AP) -- Drug maker MiddleBrook Pharmaceuticals Inc.
said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell ...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md.As part of the agreement with EGI, Edward M.
Rudnic Mr.
Thievon brings more than 17 years of pharmaceutical sales and marketing experience to MiddleBrook, and will be responsible for the successful launch and...
